Literature search services are currently unavailable. During our hosting provider's UPS upgrade we experienced a hardware failure and are currently working to resolve the issue.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

BRCA1 is a component of the RNA polymerase II holoenzyme.

The familial breast-ovarian tumor suppressor gene product BRCA1 was found to be a component of the RNA polymerase II holoenzyme by several criteria. BRCA1 was found to copurify with the holoenzyme over multiple chromatographic steps. Other tested transcription activators that could potentially contact the holoenzyme were not stably associated with the holoenzyme as determined by copurification. Antibody specific for the holoenzyme component hSRB7 specifically purifies BRCA1. Immunopurification of BRCA1 complexes also specifically purifies transcriptionally active RNA polymerase II and transcription factors TFIIF, TFIIE, and TFIIH. Moreover, a BRCA1 domain, which is deleted in about 90% of clinically relevant mutations, participates in binding to the holoenzyme complex in cells. These data are consistent with recent data identifying transcription activation domains in the BRCA1 protein and link the BRCA1 tumor suppressor protein with the transcription process as a holoenzyme-bound protein.

Pubmed ID: 9159119


  • Scully R
  • Anderson SF
  • Chao DM
  • Wei W
  • Ye L
  • Young RA
  • Livingston DM
  • Parvin JD


Proceedings of the National Academy of Sciences of the United States of America

Publication Data

May 27, 1997

Associated Grants

  • Agency: NIGMS NIH HHS, Id: GM-53504

Mesh Terms

  • BRCA1 Protein
  • Blotting, Western
  • Chromatography, Gel
  • HeLa Cells
  • Humans
  • Molecular Weight
  • RNA Polymerase II
  • Recombinant Proteins
  • Sequence Deletion
  • Trans-Activators
  • Transcription Factors
  • Transfection